Immunovant (IMVT) Other Working Capital Changes (2020 - 2021)
Immunovant (IMVT) posted Other Working Capital Changes of -$23000.0 for Q1 2025, little changed on a QoQ basis from -$23000.0 in Q4 2024, and up 91.09% year-over-year from -$12036.5 in Q1 2024.
Immunovant (IMVT) Other Working Capital Changes (2020 - 2021) Analysis & Trends
Immunovant's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$23000.0 for Q1 2025.
- Quarterly Other Working Capital Changes rose 91.09% year-over-year to -$23000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$138000.0 (up 88.23% YoY) and the FY2026 annual result came in at -$99000.0, up 28.26% from the prior year.
- Other Working Capital Changes was -$23000.0 for Q1 2025 at Immunovant, roughly flat from -$23000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at -$2000.0 in Q3 2020 and bottomed at -$544000.0 in Q4 2020.
- A 5-year average of -$227125.0 and a median of -$282500.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 1134.78% — and 2024, when it surged 92.53%.
- Immunovant's Other Working Capital Changes stood at -$275000.0 in 2021, then decreased by 4.73% to -$288000.0 in 2022, then retreated by 6.94% to -$308000.0 in 2023, then jumped by 92.53% to -$23000.0 in 2024, then changed by 0.0% to -$23000.0 in 2025.
- Business Quant data shows IMVT's Other Working Capital Changes at -$23000.0 in Q1 2025, -$23000.0 in Q4 2024, and -$23000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -360,000.00 |
| Jun 30, 2021 | -360,000.00 |
| Jun 30, 2021 | -360,000.00 |
| Mar 31, 2021 | -111,000.00 |
| Mar 31, 2021 | -111,000.00 |
| Mar 31, 2021 | -111,000.00 |
| Dec 31, 2020 | -544,000.00 |
| Dec 31, 2020 | -544,000.00 |
| Dec 31, 2020 | -544,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | -141,000.00 |
| Jun 30, 2020 | -141,000.00 |
| Jun 30, 2020 | -141,000.00 |